CAS 17372-87-1|Acid Red 87
| Common Name | Acid Red 87 | ||
|---|---|---|---|
| CAS Number | 17372-87-1 | Molecular Weight | 691.854 |
| Density | 1.02 g/mL at 20 °C | Boiling Point | 682.3ºC at 760mmHg |
| Molecular Formula | C20H6Br4Na2O5 | Melting Point | >300°C |
| MSDS | ChineseUSA | Flash Point | 11 °C |
| Symbol | GHS07 | Signal Word | Warning |
Names
| Name | eosin YS dye |
|---|---|
| Synonym | More Synonyms |
Acid Red 87 BiologicalActivity
| Description | Eosin Y (disodium) is a soluble acid red dye molecule. Eosin Y has a wide application in organic synthesis as a photoredox catalyst[1]. |
|---|---|
| Related Catalog | Research Areas >>OthersSignaling Pathways >>Others >>Others |
| References | [1]. Hari DP, König B. Synthetic applications of eosin Y in photoredox catalysis. Chem Commun (Camb). 2014;50(51):6688-6699. [2]. National Center for Biotechnology Information. PubChem Compound Summary for CID 20388, Dibromofluorescein. |
Chemical & Physical Properties
| Density | 1.02 g/mL at 20 °C |
|---|---|
| Boiling Point | 682.3ºC at 760mmHg |
| Melting Point | >300°C |
| Molecular Formula | C20H6Br4Na2O5 |
| Molecular Weight | 691.854 |
| Flash Point | 11 °C |
| Exact Mass | 687.674377 |
| PSA | 81.65000 |
| LogP | 7.59220 |
| Water Solubility | freely soluble |
Toxicological Information
CHEMICAL IDENTIFICATION |
ACUTE TOXICITY DATA - TYPE OF TEST :
- LDLo - Lowest published lethal dose
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 500 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 2344 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LDLo - Lowest published lethal dose
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - rabbit
- DOSE/DURATION :
- 300 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 14 gm/kg/78W-I
- TOXIC EFFECTS :
- Tumorigenic - equivocal tumorigenic agent by RTECS criteria Tumorigenic - tumors at site of application
MUTATION DATA - TYPE OF TEST :
- DNA repair
- TEST SYSTEM :
- Bacteria - Bacillus subtilis
- DOSE/DURATION :
- 2 mg/disc
- REFERENCE :
- TRENAF Kenkyu Nenpo--Tokyo-toritsu Eisei Kenkyusho. Annual Report of Tokyo Metropolitan Research Laboratory of Public Health. (Tokyo-toritsu Eisei Kenkyusho, 24-1, 3-chome, Hyakunin-cho, Shin-juku-ku, Tokyo 160, Japan) V.1- 1949/50- Volume(issue)/page/year: 27,153,1976 *** REVIEWS *** IARC Cancer Review:Animal Inadequate Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 15,183,1977 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - M1450 No. of Facilities: 2601 (estimated) No. of Industries: 18 No. of Occupations: 28 No. of Employees: 24024 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - M1450 No. of Facilities: 4477 (estimated) No. of Industries: 20 No. of Occupations: 29 No. of Employees: 59954 (estimated) No. of Female Employees: 28062 (estimated)
- TYPE OF TEST :
- DNA repair
- TEST SYSTEM :
- Bacteria - Bacillus subtilis
- DOSE/DURATION :
- 2 mg/disc
- REFERENCE :
- TRENAF Kenkyu Nenpo--Tokyo-toritsu Eisei Kenkyusho. Annual Report of Tokyo Metropolitan Research Laboratory of Public Health. (Tokyo-toritsu Eisei Kenkyusho, 24-1, 3-chome, Hyakunin-cho, Shin-juku-ku, Tokyo 160, Japan) V.1- 1949/50- Volume(issue)/page/year: 27,153,1976 *** REVIEWS *** IARC Cancer Review:Animal Inadequate Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 15,183,1977 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - M1450 No. of Facilities: 2601 (estimated) No. of Industries: 18 No. of Occupations: 28 No. of Employees: 24024 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - M1450 No. of Facilities: 4477 (estimated) No. of Industries: 20 No. of Occupations: 29 No. of Employees: 59954 (estimated) No. of Female Employees: 28062 (estimated)
Safety Information
| Symbol | GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H319 |
| Precautionary Statements | P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | F,T,Xn,Xi |
| Risk Phrases | R11 |
| Safety Phrases | S7-S16-S36/37-S45-S24/25-S61-S39-S26 |
| RIDADR | UN 1230 3/PG 2 |
| WGK Germany | 1 |
| RTECS | LM5850000 |
| Hazard Class | 3.0 |
| HS Code | 3822001000 |
Customs
| HS Code | 2932999099 |
|---|---|
| Summary | 2932999099. other heterocyclic compounds with oxygen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Articles127
More Articles| PI3K regulation of RAC1 is required for KRAS-induced pancreatic tumorigenesis in mice. Gastroenterology 147(6) , 1405-16.e7, (2014) New drug targets are urgently needed for the treatment of patients with pancreatic ductal adenocarcinoma (PDA). Nearly all PDAs contain oncogenic mutations in the KRAS gene. Pharmacological inhibition... | |
| Chondrogenesis of human bone marrow mesenchymal stromal cells in highly porous alginate-foams supplemented with chondroitin sulfate. Mater. Sci. Eng. C. Mater. Biol. Appl. 50 , 160-72, (2015) To overcome the limited intrinsic cartilage repair, autologous chondrocyte or bone-marrow-derived mesenchymal stromal cell (BM-MSC) was implanted into cartilage defects. For this purpose suitable bioc... | |
| Enhanced antitumor effects of the BRBP1 compound peptide BRBP1-TAT-KLA on human brain metastatic breast cancer. Sci. Rep. 5 , 8029, (2015) Novel molecularly targeted agents that block the development and metastasis of human brain metastatic breast cancer hold great promise for their translational value. In this study, we constructed a no... |
Synonyms
| Acid Red 87 |
| Benzoic acid, 2-(2,4,5,7-tetrabromo-6-hydroxy-3-oxo-3H-xanthen-9-yl)-, sodium salt (1:2) |
| dawnred |
| bromo4d |
| Eosin Y,high purity,biological stain |
| eosin yellowish |
| 2',4',5',7'-tetrabromofluorescein) disodium salt |
| RED 22 |
| eosina |
| Eosin Y,Indicator grade |
| Bronze Bromo ES |
| Eosin Y water |
| Red A |
| 2',4',5',7'-Tetrabromofluorescein disodium salt |
| D & C Red no. 21 |
| eosine acid |
| 2na |
| tetrabromofluorescein |
| C.I. Solvent Red 43 |
| Bromo acid J. TS,XL,or XX |
| Tetrabromofluorescein Sodium Salt |
| Bromoeosine |
| EINECS 241-409-6 |
| bromofluoresceic acid |
| Eosin Y,certified |
| bromob |
| Bromofluorescein |
| Disodium 2-(2,4,5,7-tetrabromo-6-oxido-3-oxo-3H-xanthen-9-yl)benzoate |
| bromots |
| bromoxx |
| Red No. 22,Eosin yellowish |
| MFCD00131580 |
| bromofl |
| D&C Red No. 22 |
| Eosine Yellowish-(YS) |
